IMX Corp. shareholders approve corporate changes.BOCA RATON, Fla.--(BUSINESS WIRE)--Dec. 1, 1995--IMX Corp. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) Friday announced it had received approval from shareholders at a special meeting held at its Boca Raton corporate offices on Nov. 21 for corporate changes previously announced including the company's redirection into marketing and distribution of certain pharmaceutical products and a reserve stock split. Approved was an agreement for IMX IMX In My eXperience IMX Interactive Music Exchange (TV show) IMX Integrated Multimedia Exchange IMX Industrywide Mortgage Exchange IMX Intermodal Marketing Extension IMX Inverse Multiplexor Corp. to acquire from Interderm Ltd. the exclusive marketing and distribution rights in the U.S.A. for a line of pharmaceutical products manufactured by Meyer-Zall Laboratories of South Africa. The products include Exorex, believed to be the most effective non-prescription medication for psoriasis. A 1-for-4 reverse split in the company's shares was also approved by the shareholders. The medication for psoriasis that the company will market is comprised of gels, creams and scalp conditioners specially formulated for deep penetration by being virtually oil and fat free as possible. Penetration is further enhanced through the use of Meyer-Zall's patent pending Trans Dermal dermal /der·mal/ (der´mal) pertaining to the dermis or to the skin. der·mal or der·mic adj. Of or relating to the skin or dermis. Process. Exorex has received the required labeler code numbers from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. to permit domestic marketing. Under the acquisition, other products available to the company include a topical muscle and joint pain reliever treatment. The company also has a product for the treatment of exzema in animals all of which still require FDA approval. The National Psoriasis Foundation The National Psoriasis Foundation is a patient-driven, non-profit US-based psoriasis education and advocacy group. The National Psoriasis Foundation's mission is to improve the quality of life of the millions of Americans with psoriasis and/or psoriatic arthritis by promoting estimates that 2% of the population in the U.S., or more than four million people, will have psoriasis during their lifetime, the disease affecting men and women equaly, particularly between the ages of 15 to 35. Between 150,000 and 260,000 new cases of psoriasis occur each year, about 10% developing into psoriatic arthritis Psoriatic Arthritis Definition Psoriatic arthritis is a form of arthritic joint disease associated with the chronic skin scaling and fingernail changes seen in psoriasis. . Acquisition of the marketing rights for the pharmaceutical products, which also includes first refusal of additional products developed, will reactivate re·ac·ti·vate v. 1. To make active again. 2. To restore the ability to function or the effectiveness of. re·ac IMX which was founded in 1982. It was engaged in importing and merchandising activities but has had virtually no assets or liabilities since 1991. President Bill Forster said the company has reestablished business operations and commenced a marketing campaign for Exorex and its new products. CONTACT: IMX Corp., Boca Raton Bill Forster, 407/998-5660 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion